In vitro induction of immunological tolerance

Area of Science:

• Immunology
• Cellular immunology
• T cell activation and tolerance

Background:

• Interleukin-2 (IL-2) induces cytotoxic effector cells with broad target specificities.
• Previous studies demonstrated IL-2's role in generating cytotoxic effectors in thymus and spleen cultures.

Purpose of the Study:

• To investigate if T cells activated by allogeneic cells (in mixed lymphocyte culture, MLC) or tumor cells (in mixed lymphocyte-tumor cell culture, MLTC) are targets for IL-2-induced cytotoxic effectors.
• To determine if IL-2-activated thymocytes can induce specific T cell tolerance in vitro.

Main Methods:

• Activation of thymocytes in vitro using recombinant IL-2 (rIL-2) for 5 days.
• Co-culture of IL-2-activated thymocytes with T cells activated in MLC or MLTC.
• Assessment of T cell elimination and reactivity using third-party allogeneic cells in MLC and MLTC.
• Use of a diffusable chamber insert system to rule out soluble factors.

Main Results:

• IL-2-activated thymocytes demonstrated cytotoxic activity against both tumor cells and activated T cells.
• IL-2-activated thymocytes effectively induced clonal deletion of T cells activated by H-2 allogeneic cells in MLC.
• Specific elimination of alloreactive T cells was observed, as remaining T cells retained reactivity to unrelated third-party allogeneic cells.
• Evidence suggests IL-2-activated thymocytes induce T cell tolerance independent of soluble factors.

Conclusions:

• IL-2-activated thymocytes serve as potent cytotoxic effectors capable of eliminating activated T cells.
• This mechanism leads to specific clonal deletion of alloreactive T cells, establishing in vitro T cell tolerance.
• The findings highlight a novel pathway for inducing antigen-specific T cell unresponsiveness.